Mativ Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US8085411069
USD
12.14
-0.04 (-0.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Mativ Holdings, Inc. stock-summary
stock-summary
Mativ Holdings, Inc.
Specialty Chemicals
Schweitzer-Mauduit International, Inc. (SWM) is a diversified producer of engineered solutions and materials for a variety of industries. The Company has two operating product line segments: Engineered Papers, and Advanced Materials and Structures. As of December 31, 2016, the Company conducted business in over 90 countries and operate 18 production locations across the world, with facilities in the United States, Canada, the United Kingdom, France, Luxembourg, Russia, Brazil, China and Poland. Through its Engineered Papers (EP) segment, the Company primarily serves the tobacco industry via the manufacture and sale of paper and reconstituted tobacco products. Through Advanced Materials & Structures (AMS) segment, the Company is a specialty producer of resin-based plastic netting through an extrusion process, as well as certain meltblown products, machined plastic core tubes, urethane films, and resin-based rolled products.
Company Coordinates stock-summary
Company Details
100 N Point Ctr E Ste 600 , ALPHARETTA GA : 30022-8263
stock-summary
Tel: 1 800 5140186
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 66 Schemes (53.01%)

Foreign Institutions

Held by 85 Foreign Institutions (7.29%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. John Rogers
Non-Executive Independent Chairman of the Board
Dr. Jeffrey Kramer
Chief Executive Officer, Director
Ms. Deborah Borg
Independent Director
Mr. Mark Bye
Independent Director
Mr. Jeffrey Keenan
Independent Director
Dr. Marco Levi
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
525 Million
(Quarterly Results - Jun 2025)
Net Profit:
-10 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 680 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.52%

stock-summary
Debt Equity

2.39

stock-summary
Return on Equity

-7.35%

stock-summary
Price to Book

1.63